426 related articles for article (PubMed ID: 29096847)
1. Immunoadsorption for autoimmune encephalitis.
Fassbender C; Klingel R; Köhler W
Atheroscler Suppl; 2017 Nov; 30():257-263. PubMed ID: 29096847
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan immunoadsorption for the treatment of autoimmune encephalitis.
Köhler W; Ehrlich S; Dohmen C; Haubitz M; Hoffmann F; Schmidt S; Klingel R; Kraft A; Neumann-Haefelin T; Topka H; Stich O; Baumgartner A; Fassbender C
Eur J Neurol; 2015 Jan; 22(1):203-6. PubMed ID: 24589025
[TBL] [Abstract][Full Text] [Related]
3. Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study.
Heine J; Ly LT; Lieker I; Slowinski T; Finke C; Prüss H; Harms L
J Neurol; 2016 Dec; 263(12):2395-2402. PubMed ID: 27604620
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmune encephalitis. New diagnosis for an old condition].
Caparó Oblitas RL
Medicina (B Aires); 2018; 78 Suppl 2():88-93. PubMed ID: 30199372
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune encephalitis.
Newman MP; Blum S; Wong RC; Scott JG; Prain K; Wilson RJ; Gillis D
Intern Med J; 2016 Feb; 46(2):148-57. PubMed ID: 26899887
[TBL] [Abstract][Full Text] [Related]
6. [Autoantibody-associated autoimmune encephalitis and cerebellitis : Clinical presentation, diagnostic work-up and treatment].
Lewerenz J; Jarius S; Wildemann B; Wandinger KP; Leypoldt F
Nervenarzt; 2016 Dec; 87(12):1293-1299. PubMed ID: 27847964
[TBL] [Abstract][Full Text] [Related]
7. Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies--perspectives for immunoadsorption.
Klingel R; Heibges A; Fassbender C
Atheroscler Suppl; 2013 Jan; 14(1):161-5. PubMed ID: 23357159
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune Encephalitis in Tunisia: Report of a Pediatric Cohort.
Douma B; Ben Younes T; Benrhouma H; Miladi Z; Zamali I; Rouissi A; Klaa H; Kraoua I; Ben Ahmed M; Ben Youssef Turki I
J Immunol Res; 2021; 2021():6666117. PubMed ID: 34056010
[TBL] [Abstract][Full Text] [Related]
9. High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis.
Jang Y; Lee ST; Kim TJ; Jun JS; Moon J; Jung KH; Park KI; Chu K; Lee SK
Sci Rep; 2018 Jan; 8(1):1012. PubMed ID: 29343812
[TBL] [Abstract][Full Text] [Related]
10. Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis.
Wickel J; Chung HY; Platzer S; Lehmann T; Prüss H; Leypoldt F; Günther A; Scherag A; Geis C;
Trials; 2020 Jul; 21(1):625. PubMed ID: 32641101
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic tools for immune causes of encephalitis.
Lascano AM; Vargas MI; Lalive PH
Clin Microbiol Infect; 2019 Apr; 25(4):431-436. PubMed ID: 30583056
[TBL] [Abstract][Full Text] [Related]
12. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
Caputo D; Iorio R; Vigevano F; Fusco L
Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
[TBL] [Abstract][Full Text] [Related]
13. [Pathophysiology and Prognostic Factors of Autoimmune Encephalitis].
Prüß H
Fortschr Neurol Psychiatr; 2016 May; 84(5):264-70. PubMed ID: 27299785
[TBL] [Abstract][Full Text] [Related]
14. Single-center study of autoimmune encephalitis-related autoantibody testing in Hungary.
Hayden Z; Böröcz K; Csizmadia Z; Balogh P; Kellermayer Z; Bodó K; Najbauer J; Berki T
Brain Behav; 2019 Dec; 9(12):e01454. PubMed ID: 31650706
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to the α3 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis.
Yamakawa M; Mukaino A; Kimura A; Nagasako Y; Kitazaki Y; Maeda Y; Higuchi O; Takamatsu K; Watari M; Yoshikura N; Ikawa M; Sugimoto I; Sakurai Y; Matsuo H; Ando Y; Shimohata T; Nakane S
J Neuroimmunol; 2020 Dec; 349():577399. PubMed ID: 32980672
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic apheresis for autoimmune encephalitis: a nationwide data collection].
Ehrlich S; Fassbender CM; Blaes C; Finke C; Günther A; Harms L; Hoffmann F; Jahner K; Klingel R; Kraft A; Lempert T; Tesch M; Thomsen J; Topka H; Jochim J; Veauthier C; Köhler W
Nervenarzt; 2013 Apr; 84(4):498-507. PubMed ID: 23325312
[TBL] [Abstract][Full Text] [Related]
17. Learning from history: Lord Brain and Hashimoto's encephalopathy.
Crotty GF; Doherty C; Solomon IH; Berry JD; Samuels MA
Pract Neurol; 2019 Aug; 19(4):316-320. PubMed ID: 31243139
[TBL] [Abstract][Full Text] [Related]
18. Immunoadsorption in neurological disorders.
Oji S; Nomura K
Transfus Apher Sci; 2017 Oct; 56(5):671-676. PubMed ID: 28919008
[TBL] [Abstract][Full Text] [Related]
19. Etoposide and immunotherapy can improve the outcome of severe anti-GABAB R encephalitis presenting with delta brush: A case report.
Xiping W; Guomin X; Haifeng W; Qi S; Liping Z
Medicine (Baltimore); 2020 Sep; 99(37):e22087. PubMed ID: 32925748
[TBL] [Abstract][Full Text] [Related]
20. Passively acquired thyroid autoantibodies from intravenous immunoglobulin in autoimmune encephalitis: Two case reports.
Uchida Y; Kato D; Adachi K; Toyoda T; Matsukawa N
J Neurol Sci; 2017 Dec; 383():116-117. PubMed ID: 29246597
[No Abstract] [Full Text] [Related]
[Next] [New Search]
